Ruscetti FW - Search Results

1

Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines.

Akiyama Y, Watanabe M, Maruyama K, Ruscetti FW, Wiltrout RH, Yamaguchi K. Akiyama Y, et al. Among authors: ruscetti fw. Gene Ther. 2000 Dec;7(24):2113-21. doi: 10.1038/sj.gt.3301353. Gene Ther. 2000. PMID: 11223993

2

Hematopoietic switch from lymphoid to granulocytic development in 3LL tumor-bearing mice.

Lee JK, Back TC, Komschlies KL, Ruscetti FW, Young HA, Wiltrout RH. Lee JK, et al. Among authors: ruscetti fw. In Vivo. 2001 Jul-Aug;15(4):255-63. In Vivo. 2001. PMID: 11695215

3

Mobilization of long-term reconstituting hematopoietic stem cells in mice by recombinant human interleukin 7.

Grzegorzewski KJ, Komschlies KL, Jacobsen SE, Ruscetti FW, Keller JR, Wiltrout RH. Grzegorzewski KJ, et al. Among authors: ruscetti fw. J Exp Med. 1995 Jan 1;181(1):369-74. doi: 10.1084/jem.181.1.369. J Exp Med. 1995. PMID: 7807018 Free PMC article.

4

Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice.

Damia G, Komschlies KL, Faltynek CR, Ruscetti FW, Wiltrout RH. Damia G, et al. Among authors: ruscetti fw. Blood. 1992 Mar 1;79(5):1121-9. Blood. 1992. PMID: 1536940 Free article.

5

Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.

Futami H, Jansen R, MacPhee MJ, Keller J, McCormick K, Longo DL, Oppenheim JJ, Ruscetti FW, Wiltrout RH. Futami H, et al. Among authors: ruscetti fw. J Immunol. 1990 Dec 15;145(12):4121-30. J Immunol. 1990. PMID: 2258610

6

Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1.

Goey H, Keller JR, Back T, Longo DL, Ruscetti FW, Wiltrout RH. Goey H, et al. Among authors: ruscetti fw. J Immunol. 1989 Aug 1;143(3):877-80. J Immunol. 1989. PMID: 2745976

7

Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites.

Grzegorzewski K, Komschlies KL, Mori M, Kaneda K, Usui N, Faltynek CR, Keller JR, Ruscetti FW, Wiltrout RH. Grzegorzewski K, et al. Among authors: ruscetti fw. Blood. 1994 Jan 15;83(2):377-85. Blood. 1994. PMID: 8286738 Free article.

8

Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor.

Grzegorzewski KJ, Komschlies KL, Franco JL, Ruscetti FW, Keller JR, Wiltrout RH. Grzegorzewski KJ, et al. Among authors: ruscetti fw. Blood. 1996 Dec 1;88(11):4139-48. Blood. 1996. PMID: 8943848 Free article.

9

In vivo and in vitro effects of TGF-beta 1 on normal and neoplastic haemopoiesis.

Ruscetti FW, Dubois C, Falk LA, Jacobsen SE, Sing G, Longo DL, Wiltrout RH, Keller JR. Ruscetti FW, et al. Ciba Found Symp. 1991;157:212-27; discussion 227-31. doi: 10.1002/9780470514061.ch14. Ciba Found Symp. 1991. PMID: 1649034 Review.

10

Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.

Grzegorzewski K, Ruscetti FW, Usui N, Damia G, Longo DL, Carlino JA, Keller JR, Wiltrout RH. Grzegorzewski K, et al. Among authors: ruscetti fw. J Exp Med. 1994 Sep 1;180(3):1047-57. doi: 10.1084/jem.180.3.1047. J Exp Med. 1994. PMID: 8064224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters